Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.65
+0.52 (2.07%)
At close: Nov 22, 2024, 4:00 PM
25.60
-0.05 (-0.19%)
After-hours: Nov 22, 2024, 7:59 PM EST
Pfizer Employees
Pfizer had 88,000 employees as of December 31, 2023. The number of employees increased by 5,000 or 6.02% compared to the previous year.
Employees
88,000
Change (1Y)
5,000
Growth (1Y)
6.02%
Revenue / Employee
$674,716
Profits / Employee
$48,318
Market Cap
145.36B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
Dec 31, 2014 | 78,300 | 600 | 0.77% |
Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
Dec 31, 2001 | 90,000 | 0 | - |
Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
Dec 31, 1994 | 40,800 | 300 | 0.74% |
Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
Sanofi | 86,088 |
Danaher | 63,000 |
Boston Scientific | 48,000 |
Bristol-Myers Squibb Company | 34,100 |
Amgen | 26,700 |
Stryker | 26,700 |
Gilead Sciences | 18,000 |
PFE News
- 1 day ago - Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript) - Seeking Alpha
- 2 days ago - Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks - Seeking Alpha
- 2 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields - Benzinga
- 2 days ago - Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam) - Business Wire
- 3 days ago - Pfizer names oncology chief and company veteran Boshoff as chief scientific officer - Market Watch
- 3 days ago - Pfizer Announces New Chief Scientific Officer and President, Research & Development - Business Wire
- 3 days ago - Pfizer names Chris Boshoff as new R&D chief, WSJ reports - Reuters
- 3 days ago - Pfizer Names New R&D Chief - WSJ